Rapid measurement of antituberculosis drug activity in vitro and in macrophages using bioluminescence.
about
Repurposing the chemical scaffold of the anti-arthritic drug Lobenzarit to target tryptophan biosynthesis in Mycobacterium tuberculosisChemoinformatic identification of novel inhibitors against Mycobacterium tuberculosis L-aspartate α-decarboxylaseA dual read-out assay to evaluate the potency of compounds active against Mycobacterium tuberculosisNovel high throughput pooled shRNA screening identifies NQO1 as a potential drug target for host directed therapy for tuberculosisDoxycycline and HIV infection suppress tuberculosis-induced matrix metalloproteinases.Real-time bioluminescence imaging of mixed mycobacterial infectionsThe efflux pump inhibitor timcodar improves the potency of antimycobacterial agents.Simple and rapid method to determine antimycobacterial potency of compounds by using autoluminescent Mycobacterium tuberculosisApplication of Fluorescent Protein Expressing Strains to Evaluation of Anti-Tuberculosis Therapeutic Efficacy In Vitro and In Vivo.The in vitro and in vivo effects of constitutive light expression on a bioluminescent strain of the mouse enteropathogen Citrobacter rodentium.Rapid in vivo assessment of drug efficacy against Mycobacterium tuberculosis using an improved firefly luciferase.Statin adjunctive therapy shortens the duration of TB treatment in mice.Bioluminescent Reporters for Rapid Mechanism of Action Assessment in Tuberculosis Drug Discovery.A Fluorescent Probe for Detecting Mycobacterium tuberculosis and Identifying Genes Critical for Cell Entry.Double recombinant Mycobacterium bovis BCG strain for screening of primary and rationale-based antimycobacterial compoundsSystem for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis.Bioluminescence for assessing drug potency against nonreplicating Mycobacterium tuberculosis.The tuberculocidal activity of polyaniline and functionalised polyanilines.Rational design of drug-like compounds targeting Mycobacterium marinum MelF protein.Effect of common and experimental anti-tuberculosis treatments on Mycobacterium tuberculosis growing as biofilms.Screening of anti-mycobacterial compounds in a naturally infected zebrafish larvae model.Determination of compound kill kinetics against Mycobacterium tuberculosis.In-vivo monitoring of infectious diseases in living animals using bioluminescence imaging.Evaluation of minor groove binders (MGBs) as novel anti-mycobacterial agents and the effect of using non-ionic surfactant vesicles as a delivery system to improve their efficacy.Reversal of Mycobacterium tuberculosis phenotypic drug resistance by 2-aminoimidazole-based small molecules.4D multimodality imaging of Citrobacter rodentium infections in mice.Rapid Whole-Cell Assay of Antitubercular Drugs Using Second-Generation FluoromycobacteriophagesReporter-Based Assays for High-Throughput Drug Screening against Mycobacterium abscessus.Methods for in vitro evaluating antimicrobial activity: A review.Imidazopyridine compounds inhibit mycobacterial growth by depleting ATP levels.
P2860
Q27689472-4470E482-484A-45C1-A80C-91E71FAACADCQ28481704-7AC55B92-2DA8-4FDC-8549-95108FCD0FA3Q28485999-AF72D90F-58C4-41BB-BE0C-A220BDC2FBD4Q28830471-CC5E7B86-0AAA-427D-BA88-C55DA4825989Q34255402-D06913DE-82D9-4B60-9287-C4C2C81B7709Q34268825-31949176-2D77-4BD5-8FF1-8EB0E352C1A2Q35076888-7FC1E47F-0F46-437F-A636-F64F63F47187Q35210821-A2D51294-8A55-4D6C-822F-B6413ABB3D65Q36641623-683BF53F-7A89-463D-B8B6-0B8C71B06AE8Q37045016-5571BA86-DE3C-46D2-8A10-F93C2BA7E0C3Q37095473-775945DB-EC40-4A59-BC90-73871F12BFA9Q37223747-A85D8D99-89ED-41B9-A4BA-737803DBAFE1Q37358682-6C3C1F36-2074-4389-9BAE-3F23730BE4ADQ37516443-3D587AAF-CE39-490E-9945-B25B405C5EB8Q38324376-363E2749-B9C7-4850-9A46-4140DFF8E006Q38817368-4CA003FC-FA64-4476-BABE-9A50BF702EA0Q39015804-6EA1A240-75A9-45C7-8E98-87A1A4677422Q39692100-9F839125-9FC9-4B1C-AA23-369F578E627BQ40066304-B9DAAFA5-EAE5-4CB7-B00C-C754D8C4C997Q40428516-A6522F27-D037-4AB0-B20B-44C0145DA8F4Q40474339-C8BC3FC8-5448-4F86-B91B-746074FB5E69Q41425744-2CACA984-6DC2-42BB-87DC-4808A5FB9BFEQ41928242-CF4A8946-CC2E-4728-9A4A-415AAD1BCBEEQ41992950-6176F2D6-4F78-4383-8ABB-AD33B975F9B1Q42074150-6CE849C7-3B75-49AB-95DD-0B3089801231Q42571117-37AAE767-09E1-45DF-8163-D6FF98FDCCE1Q42797260-D4DBB30E-7D72-4591-8576-B2D65C6B553FQ47321117-416DD935-51CB-4C14-9235-DAF5D3B56272Q49240555-4D13FB2F-8F55-4BC4-80DE-9FAEDC06DC8DQ52597961-05C0BB82-6600-4CF0-BD3B-D892DAF35ECB
P2860
Rapid measurement of antituberculosis drug activity in vitro and in macrophages using bioluminescence.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Rapid measurement of antituber ...... ophages using bioluminescence.
@en
type
label
Rapid measurement of antituber ...... ophages using bioluminescence.
@en
prefLabel
Rapid measurement of antituber ...... ophages using bioluminescence.
@en
P2860
P50
P356
P1476
Rapid measurement of antituber ...... ophages using bioluminescence.
@en
P2093
Nitya Krishnan
Taryn Fletcher
P2860
P304
P356
10.1093/JAC/DKR472
P407
P577
2011-11-17T00:00:00Z